XML 67 R48.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation and Benefit Plans (Tables)
12 Months Ended
Feb. 02, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Company's Stock Option, Performance Stock Unit and Restricted Share Activity
A summary of the balances of the Company's stock-based compensation plans as of February 2, 2025, January 28, 2024, and January 29, 2023, and changes during the fiscal years then ended is presented below: 
Stock OptionsPerformance-Based Restricted Stock UnitsRestricted SharesRestricted Stock Units
NumberWeighted-Average Exercise PriceNumberWeighted-Average Grant Date Fair ValueNumberWeighted-Average Grant Date Fair ValueNumberWeighted-Average Grant Date Fair Value
(In thousands, except per share amounts)
Balance as of January 30, 2022789 $186.10 167 $225.27 $326.70 238 $265.90 
Granted192 371.04 117 274.90 308.66 120 364.51 
Exercised/vested93 127.68 114 170.04 326.70 111 241.02 
Forfeited/expired22 286.56 307.76 — — 26 334.39 
Balance as of January 29, 2023866 $230.78 166 $295.93 $308.66 221 $323.89 
Granted213 360.00 121 296.27 370.59 132 364.63 
Exercised/vested264 160.45 104 201.56 308.66 106 294.65 
Forfeited/expired32 332.26 351.14 — 368.36 24 350.38 
Balance as of January 28, 2024783 $285.69 175 $349.84 $370.85 223 $359.12 
Granted232 383.09 125 354.40 319.19 146 375.99 
Exercised/vested95 209.54 100 310.86 371.33 101 351.61 
Forfeited/expired71 363.58 23 374.15 — — 29 371.69 
Balance as of February 2, 2025849 $314.27 177 $371.83 $317.86 239 $371.09 
Summary of Fair Value of Stock Options Issued The following are weighted averages of the assumptions that were used in calculating the fair value of stock options granted in 2024, 2023, and 2022:
 202420232022
Expected term3.75 years3.75 years3.75 years
Expected volatility37.39 %42.35 %40.00 %
Risk-free interest rate4.30 %3.49 %2.51 %
Dividend yield— %— %— %
Summary of Information About Stock Options Outstanding and Exercisable
The following table summarizes information about stock options outstanding and exercisable as of February 2, 2025:
 
Outstanding
Exercisable
Range of Exercise Prices
Number of Options
Weighted-Average Exercise Price
Weighted-Average Remaining Life (Years)
Number of Options
Weighted-Average Exercise Price
Weighted-Average Remaining Life (Years)
(In thousands, except per share amounts and years)
$85.96-$188.84
206 $169.31 1.4206 $169.31 1.4
$198.73-$356.93
142 306.87 3.685 308.49 3.2
$358.09-$358.09
165 358.09 5.139 358.09 5.0
$368.36-$381.86
132 376.52 4.260 376.70 4.1
$388.90-$502.74
204 390.46 6.1417.71 3.4

849 $314.27 4.1394 $251.93 2.6
Intrinsic value
$84,990 $64,006 
Summary Of Intrinsic Value Of Options Exercised And Full Awards Vested
The following table summarizes the intrinsic value of options exercised and awards that vested during 2024, 2023, and 2022:
202420232022
(In thousands)
Stock options$16,183 $69,316 $19,906 
Performance-based restricted stock units38,303 33,198 37,672 
Restricted shares1,163 1,661 1,152 
Restricted stock units37,972 38,016 37,275 
$93,621 $142,191 $96,005